Zeng Q - Search Results

Year	Number of Results
1983	3
1984	1
1986	3
1987	3
1988	7
1989	8
1990	3
1991	8
1992	9
1993	8
1994	10
1995	10
1996	13
1997	15
1998	30
1999	18
2000	25
2001	41
2002	38
2003	46
2004	76
2005	104
2006	99
2007	113
2008	130
2009	130
2010	132
2011	164
2012	208
2013	212
2014	242
2015	276
2016	408
2017	443
2018	502
2019	557
2020	695
2021	825
2022	959
2023	970
2024	995
2025	7

1

Understanding tumour endothelial cell heterogeneity and function from single-cell omics.

Zeng Q, Mousa M, Nadukkandy AS, Franssens L, Alnaqbi H, Alshamsi FY, Safar HA, Carmeliet P. Zeng Q, et al. Nat Rev Cancer. 2023 Aug;23(8):544-564. doi: 10.1038/s41568-023-00591-5. Epub 2023 Jun 22. Nat Rev Cancer. 2023. PMID: 37349410 Review.

2

Interventions and management on multimorbidity: An overview of systematic reviews.

Zhou Y, Dai X, Ni Y, Zeng Q, Cheng Y, Carrillo-Larco RM, Yan LL, Xu X. Zhou Y, et al. Among authors: zeng q. Ageing Res Rev. 2023 Jun;87:101901. doi: 10.1016/j.arr.2023.101901. Epub 2023 Mar 9. Ageing Res Rev. 2023. PMID: 36905961 Review.

3

Synaptic proximity enables NMDAR signalling to promote brain metastasis.

Zeng Q, Michael IP, Zhang P, Saghafinia S, Knott G, Jiao W, McCabe BD, Galván JA, Robinson HPC, Zlobec I, Ciriello G, Hanahan D. Zeng Q, et al. Nature. 2019 Sep;573(7775):526-531. doi: 10.1038/s41586-019-1576-6. Epub 2019 Sep 18. Nature. 2019. PMID: 31534217 Free PMC article.

4

Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease.

Wang Z, Zhu S, Jia Y, Wang Y, Kubota N, Fujiwara N, Gordillo R, Lewis C, Zhu M, Sharma T, Li L, Zeng Q, Lin YH, Hsieh MH, Gopal P, Wang T, Hoare M, Campbell P, Hoshida Y, Zhu H. Wang Z, et al. Among authors: zeng q. Cell. 2023 Apr 27;186(9):1968-1984.e20. doi: 10.1016/j.cell.2023.03.014. Epub 2023 Apr 10. Cell. 2023. PMID: 37040760 Free PMC article.

5

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment.

Ruan R, Li L, Li X, Huang C, Zhang Z, Zhong H, Zeng S, Shi Q, Xia Y, Zeng Q, Wen Q, Chen J, Dai X, Xiong J, Xiang X, Lei W, Deng J. Ruan R, et al. Among authors: zeng q. Mol Cancer. 2023 Mar 25;22(1):60. doi: 10.1186/s12943-023-01761-7. Mol Cancer. 2023. PMID: 36966334 Free PMC article. Review.

6

IGFBP2 expressing midlobular hepatocytes preferentially contribute to liver homeostasis and regeneration.

Lin YH, Wei Y, Zeng Q, Wang Y, Pagani CA, Li L, Zhu M, Wang Z, Hsieh MH, Corbitt N, Zhang Y, Sharma T, Wang T, Zhu H. Lin YH, et al. Among authors: zeng q. Cell Stem Cell. 2023 May 4;30(5):665-676.e4. doi: 10.1016/j.stem.2023.04.007. Cell Stem Cell. 2023. PMID: 37146585 Free PMC article.

7

Insights and progress on epidemic characteristics, genotyping, and preventive measures of PEDV in China: A review.

Li M, Pan Y, Xi Y, Wang M, Zeng Q. Li M, et al. Among authors: zeng q. Microb Pathog. 2023 Aug;181:106185. doi: 10.1016/j.micpath.2023.106185. Epub 2023 Jun 1. Microb Pathog. 2023. PMID: 37269880 Review.

8

Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapy.

Luo Q, Dong Z, Xie W, Fu X, Lin L, Zeng Q, Chen Y, Ye G, Chen M, Hu H, Wang L, Xie Y, Cai W. Luo Q, et al. Among authors: zeng q. Cell Rep. 2023 May 30;42(5):112437. doi: 10.1016/j.celrep.2023.112437. Epub 2023 Apr 24. Cell Rep. 2023. PMID: 37097818 Free article.

9

The risk factors for diabetic peripheral neuropathy: A meta-analysis.

Liu X, Xu Y, An M, Zeng Q. Liu X, et al. Among authors: zeng q. PLoS One. 2019 Feb 20;14(2):e0212574. doi: 10.1371/journal.pone.0212574. eCollection 2019. PLoS One. 2019. PMID: 30785930 Free PMC article.

10

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.

Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Zeng Q, et al. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. Lancet Oncol. 2023. PMID: 37951222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,678 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,678 results

Results by year